May 2022
1. ESMAEL A, Abebe T, Mihret A, Mussa D, et al
   Mycobacterium tuberculosis antigen-specific T cell responses in smear- negative pulmonary tuberculosis patients.
   Clin Exp Immunol. 2022 May 12. pii: 6585020. doi: 10.1093.
   

   >> Share

   
   October 2021
2. XU L, Xu Y, Zheng Y, Peng X, et al
   Differences in cytokine and chemokine profiles in cerebrospinal fluid caused by the etiology of cryptococcal meningitis and tuberculous meningitis in HIV patients.
   Clin Exp Immunol. 2021;206:82-90.
   

   >> Share

   
   April 2021
3. LOPEZ-TORRES MO, Marquina-Castillo B, Ramos-Espinosa O, Mata-Espinosa D, et al
   16alpha-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis comorbidity treatment.
   Clin Exp Immunol. 2021 Apr 18. doi: 10.1111/cei.13603.
   

   >> Share

   
   December 2020
4. ABEBE F
   Immunological basis of early clearance of Mycobacterium tuberculosis infection: the role of natural killer cells.
   Clin Exp Immunol. 2020 Dec 14. doi: 10.1111/cei.13565.
   

   >> Share

   
   November 2020
5. KOUSHA A, Farajnia S, Ansarin K, Khalili M, et al
   Does the Bacillus Calmette-Guerin vaccine have different protective effects on various strains of tuberculosis?
   Clin Exp Immunol. 2020 Nov 14. doi: 10.1111/cei.13549.
   

   >> Share

   
   October 2020
6. IMPERIALE BR, Garcia A, Minotti A, Gonzalez Montaner P, et al
   Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multidrug-resistant tuberculosis.
   Clin Exp Immunol. 2020 Oct 31. doi: 10.1111/cei.13544.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share